ResultsIQ

ResultsIQ › Latest results › Advance Agrolife Limited

Advance Agrolife Limited Q4 FY26 results press release summary

NSE: ADVANCE · BSE: 544562

Results press release of 8 May 2026, summarised by AI from the filing.

Advance Agrolife Q4 FY26 PAT at ₹74.61 million, up 422%; FY26 revenue at ₹6417.5 million, up 28%.

Key takeaways

  1. Q4 FY26 PAT ₹74.61 million, up 422% year-on-year.
  2. Unit-4 guidance Management aims to commence operations at the new Unit-4 technical manufacturing facility at Gidani by Q2 FY27, with first-phase capex of approximately ₹250 million.
  3. Backward integration Production of Pretilachlor Technical (5000 MT p.a.) and its intermediate PEDA (3700 MT p.a.) started at the Bagru facility.
  4. FY26 revenue ₹6417.5 million, up 28% over FY25.

Original filing on BSE

Advance Agrolife Limited Q1 FY27 results

As filed: Revenue ₹330 cr (+96% year on year), EBITDA ₹35.1 cr (+106% year on year), PAT ₹22.6 cr (+151% year on year), EBITDA margin 10.6% (+56 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹124 cr, EBITDA ₹13.4 cr, PAT ₹7.5 cr, EBITDA margin 10.8%. Not scored. No result for the same quarter last year. Share price after the results: −10.2% in 28 days (Nifty 500: −2.8%).
  • Q3 FY26: Revenue ₹133 cr, EBITDA ₹7.4 cr, PAT ₹3.0 cr, EBITDA margin 5.6%. Not scored. No result for the same quarter last year. Share price after the results: −21.2% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹213 cr, EBITDA ₹26.0 cr, PAT ₹16.0 cr, EBITDA margin 12.2%. Not scored. No result for the same quarter last year. Share price after the results: −9.5% in 30 days (Nifty 500: −0.1%).
  • Q1 FY26: Revenue ₹169 cr, EBITDA ₹17.0 cr, PAT ₹9.0 cr, EBITDA margin 10.1%. Not scored. No result for the same quarter last year.

Past price moves after results do not indicate future moves. Not a recommendation.

Advance Agrolife Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.